Literature DB >> 15651982

Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family.

Elangovan Gopal1, You-Jun Fei, Seiji Miyauchi, Lina Zhuang, Puttur D Prasad, Vadivel Ganapathy.   

Abstract

SMCT (sodium-coupled monocarboxylate transporter; slc5a8) is a Na+-coupled transporter for lactate, pyruvate and short-chain fatty acids. Similar to these already known substrates of SMCT, the water-soluble B-complex vitamin nicotinic acid also exists as a monocarboxylate anion (nicotinate) under physiological conditions. Therefore we evaluated the ability of SMCT to mediate the uptake of nicotinate. In mammalian cells, the cloned mouse SMCT (slc5a8) induced the uptake of nicotinate. The SMCT-induced uptake was Na+-dependent. The Michaelis constant for the uptake process was 296+/-88 microM. The Na+-activation kinetics indicated that at least two Na+ ions are involved in the process. Among the various structural analogues tested, nicotinate was the most effective substrate. Nicotinamide and methylnicotinate were not recognized by the transporter. 2-pyrazine carboxylate and isonicotinate interacted with the transporter to a moderate extent. SMCT-mediated uptake of nicotinate was inhibited by lactate and pyruvate. In the Xenopus laevis oocyte expression system, SMCT-mediated nicotinate transport was electrogenic, as evident from the nicotinate-induced inward currents under voltage-clamp conditions. Substrate-induced currents in this expression system corroborated the substrate specificity determined in the mammalian cell expression system. The kinetic parameters with regard to the affinity of the transporter for nicotinate and the Hill coefficient for Na+ activation, determined by using the oocyte expression system, were also similar to those obtained from the mammalian cell expression system. We conclude that SMCT functions not only as a Na+-coupled transporter for short-chain fatty acids and lactate but also as a Na+-coupled transporter for the water-soluble vitamin nicotinic acid.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15651982      PMCID: PMC1186720          DOI: 10.1042/BJ20041916

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Gastric uptake of nicotinic acid by bilitranslocase.

Authors:  S Passamonti; L Battiston; G L Sottocasa
Journal:  FEBS Lett       Date:  2000-09-29       Impact factor: 4.124

2.  Cloning of the human thiamine transporter, a member of the folate transporter family.

Authors:  B Dutta; W Huang; M Molero; R Kekuda; F H Leibach; L D Devoe; V Ganapathy; P D Prasad
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

3.  SLC19A3 encodes a second thiamine transporter ThTr2.

Authors:  A Rajgopal; A Edmondnson; I D Goldman; R Zhao
Journal:  Biochim Biophys Acta       Date:  2001-11-29

Review 4.  Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers.

Authors:  H C Lee
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

Review 5.  Coordination of Ca2+ signalling by NAADP.

Authors:  S Patel; G C Churchill; A Galione
Journal:  Trends Biochem Sci       Date:  2001-08       Impact factor: 13.807

Review 6.  NAADP: an atypical Ca2+-release messenger?

Authors:  Armando A Genazzani; Richard A Billington
Journal:  Trends Pharmacol Sci       Date:  2002-04       Impact factor: 14.819

7.  Nicotinic acid transport mediated by pH-dependent anion antiporter and proton cotransporter in rabbit intestinal brush-border membrane.

Authors:  H Takanaga; H Maeda; H Yabuuchi; I Tamai; H Higashida; A Tsuji
Journal:  J Pharm Pharmacol       Date:  1996-10       Impact factor: 3.765

8.  Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes.

Authors:  Anne-Marie Rodriguez; Barbara Perron; Ludovic Lacroix; Bernard Caillou; Gérard Leblanc; Martin Schlumberger; Jean-Michel Bidart; Thierry Pourcher
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

9.  PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.

Authors:  Sorin Tunaru; Jukka Kero; Annette Schaub; Christian Wufka; Andree Blaukat; Klaus Pfeffer; Stefan Offermanns
Journal:  Nat Med       Date:  2003-02-03       Impact factor: 53.440

10.  Molecular identification of high and low affinity receptors for nicotinic acid.

Authors:  Alan Wise; Steven M Foord; Neil J Fraser; Ashley A Barnes; Nabil Elshourbagy; Michelle Eilert; Diane M Ignar; Paul R Murdock; Klaudia Steplewski; Andrew Green; Andrew J Brown; Simon J Dowell; Philip G Szekeres; David G Hassall; Fiona H Marshall; Shelagh Wilson; Nicholas B Pike
Journal:  J Biol Chem       Date:  2003-01-09       Impact factor: 5.157

View more
  33 in total

1.  Comparative genomics and functional analysis of the NiaP family uncover nicotinate transporters from bacteria, plants, and mammals.

Authors:  Linda Jeanguenin; Aurora Lara-Núñez; Dmitry A Rodionov; Andrei L Osterman; Nataliya Y Komarova; Doris Rentsch; Jesse F Gregory; Andrew D Hanson
Journal:  Funct Integr Genomics       Date:  2011-09-28       Impact factor: 3.410

2.  Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: a RPE specific phenomenon.

Authors:  Sudha Ananth; Lina Zhuang; Elangovan Gopal; Shiro Itagaki; Babu Ellappan; Sylvia B Smith; Vadivel Ganapathy; Pamela Martin
Journal:  Biochem Biophys Res Commun       Date:  2010-02-21       Impact factor: 3.575

3.  Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate.

Authors:  Muthusamy Thangaraju; Senthil K Karunakaran; Shiro Itagaki; Elangovan Gopal; Selvakumar Elangovan; Puttur D Prasad; Vadivel Ganapathy
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

4.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

5.  Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract.

Authors:  Elangovan Gopal; Seiji Miyauchi; Pamela M Martin; Sudha Ananth; Penny Roon; Sylvia B Smith; Vadivel Ganapathy
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

6.  Retinal transfer of nicotinate by H+ -monocarboxylate transporter at the inner blood-retinal barrier.

Authors:  Masanori Tachikawa; Koji Murakami; Pamela M Martin; Ken-ichi Hosoya; Vadivel Ganapathy
Journal:  Microvasc Res       Date:  2011-06-29       Impact factor: 3.514

7.  Cloning and functional identification of slc5a12 as a sodium-coupled low-affinity transporter for monocarboxylates (SMCT2).

Authors:  Sonne R Srinivas; Elangovan Gopal; Lina Zhuang; Shirou Itagaki; Pamela M Martin; You-Jun Fei; Vadivel Ganapathy; Puttur D Prasad
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

8.  Identification of the multivalent PDZ protein PDZK1 as a binding partner of sodium-coupled monocarboxylate transporter SMCT1 (SLC5A8) and SMCT2 (SLC5A12).

Authors:  Sunena Srivastava; Kiyoshi Nakagawa; Xin He; Toru Kimura; Toshiyuki Fukutomi; Seiji Miyauchi; Hiroyuki Sakurai; Naohiko Anzai
Journal:  J Physiol Sci       Date:  2019-01-02       Impact factor: 2.781

9.  GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.

Authors:  Muthusamy Thangaraju; Gail A Cresci; Kebin Liu; Sudha Ananth; Jaya P Gnanaprakasam; Darren D Browning; John D Mellinger; Sylvia B Smith; Gregory J Digby; Nevin A Lambert; Puttur D Prasad; Vadivel Ganapathy
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

10.  The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition.

Authors:  Dapeng Cui; Marilyn E Morris
Journal:  Drug Metab Dispos       Date:  2009-04-23       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.